{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:10:45Z","timestamp":1792656645244,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/modpathol.2013.173","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T23:10:12Z","timestamp":1388704212000},"page":"S1-S16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"special_numbering":"S1","title":["Gastrointestinal stromal tumors: what do we know now?"],"prefix":"10.1016","volume":"27","author":[{"given":"Christopher L","family":"Corless","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.173_bib1","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v12.i14.2223","article-title":"Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong","volume":"12","author":"Chan","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1038\/modpathol.2013.173_bib2","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.ejca.2005.09.009","article-title":"Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study","volume":"41","author":"Goettsch","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era","volume":"103","author":"Nilsson","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2013.173_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.21167","article-title":"Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study","volume":"117","author":"Tryggvason","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib5","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib6","first-page":"3","article-title":"Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics","volume":"54","author":"Miettinen","year":"2003","journal-title":"Pol J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1038\/modpathol.2013.173_bib8","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","article-title":"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status","volume":"165","author":"West","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.173_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","article-title":"The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains","volume":"241","author":"Hanks","year":"1988","journal-title":"Science"},{"key":"10.1038\/modpathol.2013.173_bib12","first-page":"1633","article-title":"KIT mutation portends poor prognosis in gastrointestinal stromal\/smooth muscle tumors","volume":"78","author":"Ernst","year":"1998","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2013.173_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9440(10)65250-9","article-title":"Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas","volume":"154","author":"Lasota","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib14","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1200\/JCO.2002.03.095","article-title":"Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors","volume":"20","author":"Singer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib15","first-page":"4297","article-title":"Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1053\/j.gastro.2006.01.043","article-title":"Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis","volume":"130","author":"Andersson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib17","first-page":"1361","article-title":"Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach","volume":"28","author":"Cho","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1038\/modpathol.2013.173_bib18","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.v11.i25.3948","article-title":"Prognostic value of KIT mutation in gastrointestinal stromal tumors","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1038\/modpathol.2013.173_bib19","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1200\/JCO.2005.19.554","article-title":"Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3748\/wjg.v11.i7.1052","article-title":"Analysis of CD117-negative gastrointestinal stromal tumors","volume":"11","author":"Tzen","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1038\/modpathol.2013.173_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","article-title":"Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9440(10)64946-2","article-title":"KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors","volume":"156","author":"Lux","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2008.2","article-title":"Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases","volume":"21","author":"Lasota","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.173_bib24","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","article-title":"Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor","volume":"96","author":"Heinrich","year":"2000","journal-title":"Blood"},{"key":"10.1038\/modpathol.2013.173_bib26","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.1037763100","article-title":"Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase","volume":"100","author":"Sommer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.173_bib27","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-05-0891","article-title":"A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E","volume":"65","author":"Rubin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/gut.51.6.793","article-title":"Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours","volume":"51","author":"Chen","year":"2002","journal-title":"Gut"},{"key":"10.1038\/modpathol.2013.173_bib29","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1097\/01.pas.0000173024.79852.08","article-title":"Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features","volume":"29","author":"O'riain","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib30","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/sj.onc.1207525","article-title":"Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Duensing","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.173_bib31","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1073\/pnas.0511076103","article-title":"Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor","volume":"103","author":"Rossi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.173_bib32","first-page":"708","article-title":"Protein kinase C theta (PKC{theta}) is selectively expressed and constitutively phosphorylatedd in gastrointestinal stromal tumors (GISTs)","volume":"2004","author":"Duensing","year":"2004","journal-title":"AACR Meet Abstr"},{"key":"10.1038\/modpathol.2013.173_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nature09409","article-title":"ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours","volume":"467","author":"Chi","year":"2010","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.173_bib34","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib35","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/1078-0432.CCR-04-2245","article-title":"Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation","volume":"11","author":"Antonescu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/modpathol.2008.46","article-title":"Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression","volume":"21","author":"Chen","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.173_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1038\/modpathol.2013.173_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0016-5085(03)01046-1","article-title":"Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors","volume":"125","author":"Hirota","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.onc.1208358","article-title":"Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors","volume":"24","author":"Kang","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.173_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1074\/jbc.M607012200","article-title":"The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells","volume":"282","author":"Matei","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2013.173_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/path.1546","article-title":"Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity","volume":"202","author":"Debiec-Rychter","year":"2004","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib42","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1158\/0008-5472.CAN-04-0559","article-title":"Protein kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs)","volume":"64","author":"Duensing","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/gcc.20408","article-title":"Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status","volume":"46","author":"Wozniak","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2013.173_bib44","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/sj.onc.1208056","article-title":"Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles","volume":"23","author":"Subramanian","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.173_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.3800136","article-title":"Differential expression of KIT\/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site","volume":"17","author":"Wasag","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.173_bib46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200407000-00007","article-title":"KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications","volume":"28","author":"Medeiros","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib47","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.humpath.2004.07.008","article-title":"Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene","volume":"35","author":"Sakurai","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.173_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1525-1578(10)60510-7","article-title":"Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors","volume":"6","author":"Wardelmann","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2013.173_bib49","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/labinvest.3700122","article-title":"A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential","volume":"84","author":"Lasota","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2013.173_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1309\/AJCPPCKGA2QGBJ1R","article-title":"BRAF mutation status in gastrointestinal stromal tumors","volume":"133","author":"Hostein","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2013.173_bib51","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.pas.0000159775.77912.15","article-title":"NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics","volume":"29","author":"Andersson","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib52","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2006.07.002","article-title":"Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA","volume":"131","author":"de Raedt","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01.pas.0000213318.66800.94","article-title":"Multiple gastrointestinal stromal tumors: clinicopathologic and genetic analysis of 12 patients","volume":"31","author":"Kang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/hmg\/ddl016","article-title":"Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients","volume":"15","author":"Maertens","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1038\/modpathol.2013.173_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.pas.0000176433.81079.bd","article-title":"Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib56","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1136\/jmg.2006.043075","article-title":"Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1","volume":"44","author":"Stewart","year":"2007","journal-title":"J Med Genet"},{"key":"10.1038\/modpathol.2013.173_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/path.1487","article-title":"Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients","volume":"202","author":"Kinoshita","year":"2004","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0b013e3182671178","article-title":"Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation","volume":"37","author":"Miettinen","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib59","doi-asserted-by":"crossref","unstructured":"Mason E, Hornick JL . Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod Pathol advance online publication, 7 June 2013 (e-pub ahead of print).","DOI":"10.1038\/modpathol.2013.86"},{"key":"10.1038\/modpathol.2013.173_bib60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","author":"Killian","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1038\/modpathol.2013.173_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnci\/djr130","article-title":"SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing","volume":"103","author":"Pantaleo","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2013.173_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.2012.153","article-title":"Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors","volume":"26","author":"Wagner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.173_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","article-title":"Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors","volume":"37","author":"Dwight","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib64","unstructured":"Pantaleo MA, Astolfi A, Urbini M et al. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT\/PDGFRA wild-type GIST. Eur J Hum Genet 2013, (e-pub ahead of print)."},{"key":"10.1038\/modpathol.2013.173_bib65","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/modpathol.2012.186","article-title":"SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors","volume":"3","author":"Oudijk","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.173_bib66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1471-2407-12-408","article-title":"SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors","volume":"14","author":"Italiano","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2013.173_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/gcc.22023","article-title":"Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors","volume":"52","author":"Belinsky","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2013.173_bib68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/fon.12.170","article-title":"Expression of IGF-1 receptor in KIT\/PDGF receptor-a wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction","volume":"9","author":"Nannini","year":"2013","journal-title":"Future Oncol"},{"key":"10.1038\/modpathol.2013.173_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.mph.0000157790.81329.47","article-title":"Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature","volume":"27","author":"Prakash","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1038\/modpathol.2013.173_bib70","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1158\/0008-5472.CAN-07-1938","article-title":"Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors","volume":"67","author":"Janeway","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib71","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-07-1984","article-title":"Molecular characterization of pediatric gastrointestinal stromal tumors","volume":"14","author":"Agaram","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/74.6.543","article-title":"Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence","volume":"74","author":"Carney","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/modpathol.2013.173_bib73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D","article-title":"Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa","volume":"92","author":"Beghini","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2013.173_bib74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.gastro.2003.10.079","article-title":"PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor","volume":"126","author":"Chompret","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib75","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1053\/gast.2002.33024","article-title":"Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene","volume":"122","author":"Hirota","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib76","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0002-9440(10)64795-5","article-title":"Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors","volume":"157","author":"Isozaki","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/gast.2001.20880","article-title":"Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene","volume":"120","author":"Maeyama","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/1209","article-title":"Familial gastrointestinal stromal tumours with germline mutation of the KIT gene","volume":"19","author":"Nishida","year":"1998","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2013.173_bib79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.pas.0000213307.05811.f0","article-title":"Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations","volume":"31","author":"Agaimy","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib80","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0002-9440(10)61103-0","article-title":"KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size","volume":"160","author":"Corless","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib81","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.humpath.2006.07.002","article-title":"High incidence of microscopic gastrointestinal stromal tumors in the stomach","volume":"37","author":"Kawanowa","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.173_bib82","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.humpath.2011.01.024","article-title":"Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study","volume":"42","author":"Muenst","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.173_bib83","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/PAS.0b013e3181ef7431","article-title":"Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size","volume":"34","author":"Rossi","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib84","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1158\/1078-0432.CCR-08-0622","article-title":"Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity","volume":"14","author":"Gasparotto","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib85","first-page":"275","article-title":"Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies","volume":"82","author":"Bergmann","year":"1998","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1038\/modpathol.2013.173_bib86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0165-4608(01)00395-8","article-title":"Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation","volume":"128","author":"Debiec-Rychter","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/modpathol.2013.173_bib87","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1349-7006.2000.tb00910.x","article-title":"Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor","volume":"91","author":"Fukasawa","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib88","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/hupa.2002.124124","article-title":"Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations","volume":"33","author":"Heinrich","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.173_bib89","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<633::AID-IJC6>3.0.CO;2-5","article-title":"Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors","volume":"85","author":"Kim","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib90","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/gcc.20439","article-title":"Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors","volume":"46","author":"Assamaki","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2013.173_bib91","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.2128","article-title":"An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications","volume":"211","author":"Gunawan","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib92","first-page":"3230","article-title":"DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors","volume":"56","author":"El Rifai","year":"1996","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib93","first-page":"1461","article-title":"Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal\/smooth muscle tumors","volume":"79","author":"O'Leary","year":"1999","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2013.173_bib94","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1158\/1078-0432.CCR-05-2083","article-title":"Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome","volume":"12","author":"Schurr","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib95","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C","article-title":"High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci","volume":"27","author":"el-Rifai","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2013.173_bib96","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00432-008-0514-z","article-title":"Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q","volume":"135","author":"Yamamoto","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib97","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s10620-009-1061-4","article-title":"Gene expression profiling of human gastrointestinal stromal tumors according to its malignant potential","volume":"55","author":"Hur","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1038\/modpathol.2013.173_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cncr.21113","article-title":"9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations","volume":"104","author":"Perrone","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2013.173_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1309\/MJ4XN2M57HNC8X5H","article-title":"Role of p16\/INK4a in gastrointestinal stromal tumor progression","volume":"122","author":"Ricci","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2013.173_bib100","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/modpathol.3800199","article-title":"Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors","volume":"17","author":"Sabah","year":"2004","journal-title":"Mod Pathol"},{"issue":"2 Pt 1","key":"10.1038\/modpathol.2013.173_bib101","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1078-0432.638.11.2","article-title":"Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study","volume":"11","author":"Schneider-Stock","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib102","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2559.2005.02071.x","article-title":"The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome","volume":"46","author":"Feakins","year":"2005","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2013.173_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/106689690000800208","article-title":"Predicting metastatic risk of gastrointestinal stromal tumors: role of cell proliferation and cell cycle regulatory proteins","volume":"8","author":"Panizo-Santos","year":"2000","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib104","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-08-3297","article-title":"Cell cycle\/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors","volume":"15","author":"Romeo","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/labinvest.3700284","article-title":"Patterns of gene amplification in gastrointestinal stromal tumors (GIST)","volume":"85","author":"Tornillo","year":"2005","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2013.173_bib106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2013.173_bib107","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"Joensuu","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2013.173_bib108","first-page":"1a","article-title":"STI571, an active drug in metastatic gastrointestinal stromal tumors (GIST) an EORTC phase I study [abstract]","volume":"20","author":"Van Oosterom","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib109","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2013.173_bib110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1200\/JCO.2007.13.4452","article-title":"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033","volume":"26","author":"Blanke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib111","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2013.173_bib112","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2009.24.2099","article-title":"Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients","volume":"28","author":"Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST)","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib113","doi-asserted-by":"crossref","first-page":"609s","DOI":"10.1200\/jco.2011.29.15_suppl.10016","article-title":"Follow-up results after 9 years (yrs) of the ongoing, phase II B2222 trial of imatinib mesylate (IM) in patients (pts) with metastatic or unresectable KIT+ gastrointestinal stromal tumors (GIST)","volume":"29","author":"von Mehren","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib114","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"DeMatteo","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2013.173_bib115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"key":"10.1038\/modpathol.2013.173_bib116","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjc.6605743","article-title":"A prospective epidemiological study of new incident GISTs during two consecutive years in Rh\u00f4ne Alpes region: incidence and molecular distribution of GIST in a European region","volume":"103","author":"Cassier","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib117","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","article-title":"Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib119","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000478-200305000-00006","article-title":"Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00384-013-1655-3","article-title":"Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach","volume":"28","author":"Agaimy","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1038\/modpathol.2013.173_bib121","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1470-2045(10)70222-9","article-title":"Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial","volume":"11","author":"Le Cesne","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2013.173_bib122","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1078-0432.CCR-06-1508","article-title":"Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors","volume":"13","author":"Agaram","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib123","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PAS.0b013e31826c1761","article-title":"Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy","volume":"37","author":"Antonescu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.173_bib124","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1200\/JCO.2008.17.4284","volume":"26","author":"Heinrich","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","article-title":"Kit mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours","volume":"42","author":"Debiec-Rychter","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib126","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1200\/JCO.2007.15.7461","article-title":"Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor","volume":"26","author":"Heinrich","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib127","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1200\/JCO.2005.14.068","article-title":"PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib","volume":"23","author":"Corless","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib128","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1053\/j.gastro.2006.09.017","article-title":"Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity","volume":"131","author":"Weisberg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1073\/pnas.0812413106","article-title":"KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients","volume":"106","author":"Gajiwala","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.173_bib130","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1158\/1078-0432.CCR-11-3025","article-title":"Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era","volume":"18","author":"Cassier","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib131","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jcp.2009.064550","article-title":"V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours","volume":"62","author":"Agaimy","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2013.173_bib132","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","article-title":"Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors","volume":"47","author":"Agaram","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2013.173_bib133","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/pbc.21909","article-title":"Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib","volume":"52","author":"Janeway","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1038\/modpathol.2013.173_bib134","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/0008-5472.CAN-04-0085","article-title":"A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors","volume":"64","author":"Chen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.gastro.2004.11.020","article-title":"Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants","volume":"128","author":"Debiec-Rychter","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2013.173_bib136","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1470-2045(05)70321-1","article-title":"Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour","volume":"6","author":"Grimpen","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2013.173_bib137","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","article-title":"Molecular correlates of imatinib resistance in gastrointestinal stromal tumors","volume":"24","author":"Heinrich","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib138","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10120-006-0368-5","article-title":"Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment","volume":"9","author":"Koyama","year":"2006","journal-title":"Gastric Cancer"},{"key":"10.1038\/modpathol.2013.173_bib139","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/sj.bjc.6601819","article-title":"Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation","volume":"90","author":"Wakai","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2013.173_bib140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(05)70097-8","article-title":"Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations","volume":"6","author":"Wardelmann","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2013.173_bib141","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/path.2382","article-title":"Heterogeneity of kinase inhibitor resistance mechanisms in GIST","volume":"216","author":"Liegl","year":"2008","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.173_bib142","doi-asserted-by":"crossref","unstructured":"Nishida T, Kanda T, Nishitani A et al. Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor. Cancer Sci 2008.","DOI":"10.1111\/j.1349-7006.2008.00727.x"},{"key":"10.1038\/modpathol.2013.173_bib143","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12032-007-9014-2","article-title":"Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors","volume":"25","author":"Lim","year":"2008","journal-title":"Med Oncol"},{"issue":"Suppl 1","key":"10.1038\/modpathol.2013.173_bib144","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminoncol.2011.01.018","article-title":"Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors","volume":"38","author":"Demetri","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib145","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2013.173_bib146","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10147-008-0822-y","article-title":"Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene","volume":"14","author":"Nishida","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib147","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(12)61857-1","article-title":"Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. [abstract]","volume":"381","author":"Demetri","year":"2013","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2013.173_bib148","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-10-3224","article-title":"The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile","volume":"71","author":"Eide","year":"2011","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.173_bib149","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.10007","article-title":"In vitro activity of novel KIT\/PDGFRA switch pocket kinase inhibitors against mutations associated with drug-resistant GI stromal tumors","volume":"28","author":"Heinrich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.173_bib150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.semdp.2006.08.006","article-title":"KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Lasota","year":"2006","journal-title":"Semin Diagn Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:12:20Z","timestamp":1760231540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222035128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":150,"alternative-id":["S0893395222035128"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.173","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718226970.793565816","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal stromal tumors: what do we know now?","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}